July 6, 2023
- June 27, 2023 - Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed). See NOFO RFA-NS-24-009
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to change the receipt date for RFA-NS-24-009 - Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed).
Current Reads:
Open Date (Earliest Submission Date)
August 06, 2023
Letter of Intent Due Date(s)
Not Applicable
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| September 06, 2023 | September 06, 2023 | Not Applicable | March 2024 | May 2024 | July 2024 |
All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Expiration Date
September 07, 2023
Revised to Read:
Open Date (Earliest Submission Date)
October 15, 2023
Letter of Intent Due Date(s)
Not Applicable
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| November 15, 2023 | November 15, 2023 | Not Applicable | February 2024 | May 2024 | July 2024 |
All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Expiration Date
November 16, 2023
No other changes to this NOFO.
Timothy LaVaute, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1447
Email: [email protected]
and Human Services (HHS)
